Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × dubermatinib × Clear all

NCT04518345 2023-02-06

TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute